Skip to main content
Home Life Sciences

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us

See what’s new.

https://otc.duke.edu/wp-content/uploads/2024/04/LumiSystem_Family_withoutLogo_v5-1000.jpg

Lumicell’s Cutting-Edge Imaging Platform Receives Historic FDA Approval to Illuminate Residual Breast Cancer

Lumicell is an MIT start-up based on breast cancer imaging technology co-developed by Dr. David Kirsch (Radiation Oncology, SOM).

Read More

https://otc.duke.edu/wp-content/uploads/2024/04/plug-and-play-logo.png

Plug and Play Announces Inaugural Batch of Startups Selected for their Medtech Program

Duke start-up Sparta Biomedical has been selected for Batch 1 of Plug and Play's Warsaw Medtech program in Spring 2024.

Read More

https://otc.duke.edu/wp-content/uploads/2024/03/meyer_kate_magnify.png

The Power and Promise of RNA

Several Duke researchers studying RNA modification are profiled in this Magnify article from the School of Medicine. Tech available for licensing!

Read More

https://otc.duke.edu/wp-content/uploads/2024/03/TechCommBootcamp_20240223_5862.jpg

Transforming inventions into products: Duke charts a path for student innovators

Duke’s innovation ecosystem collaborates to offer Duke graduate and professional students a hands-on technology commercialization bootcamp – focused on student-led inventions.

Read More

https://otc.duke.edu/wp-content/uploads/2023/10/BMI_OrganBank_Logo.jpg

BMI OrganBank, Atrium Health and LifeShare Carolinas Partner to Launch Nation’s First Organ Banking Technology

BMI OrganBank licensed perfusion tech from the Duke Ex-Vivo Organ Lab, led by Drs. Andrew S. Barbas and Matthew Hartwig (Surgery, SOM).

Read More

https://otc.duke.edu/wp-content/uploads/2024/02/servier-logo.png

FDA and EMA Accept Vorasidenib Regulatory Submissions for the Treatment of IDH-mutant diffuse glioma

This application of vorasidenib is based on licensed technology developed by Dr. Darell Bigner (Neurobiology, SOM) and colleagues.

Read More

https://otc.duke.edu/wp-content/uploads/2024/02/insoma-stefan-profile-OTC-DCP-2024-featured-image-FINAL.jpg

How Stefan Roberts and inSoma Bio are upgrading fat grafting with Duke technology and support

Learn how the Duke community is helping BME Ph.D. graduate Stefan Roberts and his start-up inSoma Bio commercialize technology he developed in the lab of Professor Ashutosh Chilkoti.

Read More

https://otc.duke.edu/wp-content/uploads/2024/02/basking-biosciences-logo.png

Basking Biosciences Announces Close of $55 Million Financing to Accelerate Clinical Development for First Reversible Thrombolytic for Ischemic Stroke

Basking Biosciences, a start-up out of the lab of Professor Bruce Sullenger (Surgery, SOM), is developing a next-gen treatment for stroke.

Read More

https://otc.duke.edu/wp-content/uploads/2024/01/otc-timeline-announcement-featured-image.jpg

Duke is Inventive: A Century of Innovation at Duke University

A new Centennial physical and digital exhibit from OTC collects innovations, inventors, and companies spinning out of Duke University.

Read More

1 2 3 27